In July 2005 Miraca Holdings Inc. was set up to combine Fujirebio Inc., the leading in-vitro diagnostics company, and SRL, Inc., the top provider of clinical laboratory testing services in Japan, and started its operation to integrate management resources and maximize the group's corporate value.
The Origin of "Miraca"
Fujirebio and SRL have led the way in the development of clinical diagnostics and promotion of clinical testing, respectively. Both companies have enjoyed an excellent reputation within the healthcare industry for decades.
The new holding company, "Miraca", was thus named after its slogan, "Looking ahead, we will remain committed and contribute to the development of science." "Miraca" comes from abbreviating and combining two Japanese words: "Mirai" (future) and "Cagaku" (science).
|
